Search research articles
Contact Us
Filters
Showing results (71-80 of 176) with videos related to
Page
of 18
Sort By:
The American Journal of Surgical Pathology
|
July 16, 2014
Cytotoxic T-cell and NK-cell lymphomas: current questions and controversies
Steven H Swerdlow, Elaine S Jaffe, Pierre Brousset, et al.
Journal of Cutaneous Pathology
|
April 9, 2025
Primary Cutaneous Anaplastic Large Cell Lymphoma With TCR-γδ Expression: A Case Series of Eleven Patients of a Rare Immunophenotypic Variant
Anna Sarah Erem, Werner Kempf, Christina Mitteldorf, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 17, 2010
Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: evaluation of the long-term outcome
Pier Luigi Zinzani, Letizia Gandolfi, Vittorio Stefoni, et al.
Haematologica
|
March 28, 2008
Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice
Brunangelo Falini, Maria Paola Martelli, Cristina Mecucci, et al.
World Journal of Gastroenterology
|
June 20, 2014
Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma
Maria Caterina Pallotti, Margherita Nannini, Claudio Agostinelli, et al.
Cellular Immunology
|
October 13, 2022
Dampening of cytotoxic innate lymphoid cells: A new tumour immune escape mechanism in B cell non-Hodgkin's lymphoma
Stefania Roma, Chiara Camisaschi, Patrizia Mancuso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2013
Ligand-dependent activation of EGFR in follicular dendritic cells sarcoma is sustained by local production of cognate ligands
William Vermi, Emanuele Giurisato, Silvia Lonardi, et al.
Cancer
|
October 11, 2005
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients
Enrica Marchi, Lapo Alinari, Monica Tani, et al.
Haematologica
|
February 13, 2008
NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia
Brunangelo Falini, Cristina Mecucci, Giuseppe Saglio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2007
Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma
Pier Luigi Zinzani, Gerardo Musuraca, Monica Tani, et al.
Page
of 18
Search research articles
Search
Showing results (71-80 of 176) with videos related to
Sort By:
Page
of 18
The American Journal of Surgical Pathology
|
July 16, 2014
Cytotoxic T-cell and NK-cell lymphomas: current questions and controversies
Steven H Swerdlow, Elaine S Jaffe, Pierre Brousset, et al.
Journal of Cutaneous Pathology
|
April 9, 2025
Primary Cutaneous Anaplastic Large Cell Lymphoma With TCR-γδ Expression: A Case Series of Eleven Patients of a Rare Immunophenotypic Variant
Anna Sarah Erem, Werner Kempf, Christina Mitteldorf, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 17, 2010
Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: evaluation of the long-term outcome
Pier Luigi Zinzani, Letizia Gandolfi, Vittorio Stefoni, et al.
Haematologica
|
March 28, 2008
Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice
Brunangelo Falini, Maria Paola Martelli, Cristina Mecucci, et al.
World Journal of Gastroenterology
|
June 20, 2014
Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma
Maria Caterina Pallotti, Margherita Nannini, Claudio Agostinelli, et al.
Cellular Immunology
|
October 13, 2022
Dampening of cytotoxic innate lymphoid cells: A new tumour immune escape mechanism in B cell non-Hodgkin's lymphoma
Stefania Roma, Chiara Camisaschi, Patrizia Mancuso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2013
Ligand-dependent activation of EGFR in follicular dendritic cells sarcoma is sustained by local production of cognate ligands
William Vermi, Emanuele Giurisato, Silvia Lonardi, et al.
Cancer
|
October 11, 2005
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients
Enrica Marchi, Lapo Alinari, Monica Tani, et al.
Haematologica
|
February 13, 2008
NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia
Brunangelo Falini, Cristina Mecucci, Giuseppe Saglio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2007
Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma
Pier Luigi Zinzani, Gerardo Musuraca, Monica Tani, et al.
Page
of 18